VitalConnect delivers a cost-effective, 24/7 remote patient monitoring platform that outperforms existing patient monitoring devices on the market.
Manufacturer positioned to deliver solutions to ease space constraints in the fast-growing cell and gene therapy sector.
Strategic Investment Expected to Help Accelerate Cardiac Monitoring and Strategic Relationship Aims to Create Improved Disease State Treatment Models
Addition of Experienced Financial Leader Bolsters Strong Management Team
Getz adds 25 Years of Financial and Healthcare Leadership to Growing Company
WATERTOWN, Massachusetts—/PRNewswire/—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders,…